Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia
American Journal of Hematology · 2025
DOI: 10.1002/ajh.70023 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Carmen Mestre-Durán und 23 weiteren Autor:innen. Beteiligte Einrichtung: CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Interleukin-15, Killer Cells, Natural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: CRIS Cancer Foundation, Ministry of Universities through the European Union NextGenerationEU, Universidad de Castilla-La Mancha.
Abstract (Originalsprache)
A Phase I/II clinical trial was conducted in pediatric patients with high-risk malignancies to assess the safety and efficacy of NK cell infusion post-haplo-HSCT. Patients received either alloreactive NK cells from KIR/HLA-mismatched donors or IL-15-stimulated NK cells from KIR/HLA-matched donors, across three dose-escalating cohorts. The IL15-NK cell infusion product demonstrated enhanced activating receptor expression and functional capacity. Increased NKG2D expression was observed in NK cells from patients receiving IL15-NK cells. One-year follow-up showed accelerated immune reconstitution in both the allo-NK and IL15-NK cell arms. IL15-NK recipients exhibited a pro-inflammatory cytokine profile (IL-2, IL-4, IL-6, IFN-γ). Elevated CD69 expression was associated with a higher risk of transplant-related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain.
- Biostatistics Unit, Institute for Health Research (IdiPAZ), Madrid, Spain.
- Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Pediatric Hemato-Oncology, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
- Pediatric Hemato-Oncology, Niño Jesús University Children's Hospital, Madrid, Spain.
ORCID-Profile: Carmen Mestre-Durán, Cristina Beléndez, Jordi Cano-Ochando, María Eugenia Fernández-Santos, Antonio Pérez-Martínez
Förderung
- CRIS Cancer Foundation
- Ministry of Universities through the European Union NextGenerationEU
- Universidad de Castilla-La Mancha
- Instituto de Salud Carlos III
Zitieren
APA
Mestre-Durán, C., León-Triana, O., Bareke, H., Pertíñez, L., Clares-Villa, L., Bueno, D., Lozano-Ojalvo, D., Navarro-Zapata, A., Sisinni, L., Badell-Serra, I., González-Vicent, M., Beléndez, C., Palomo-Moraleda, P., Mozo, Y., Galán, V., Artázcoz, M. F., Echecopar, C., Gasior, M., Al-Akioui, K., …, & Pérez-Martínez, A. (2025). Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.70023
Vancouver
Mestre-Durán C, León-Triana O, Bareke H, Pertíñez L, Clares-Villa L, Bueno D, et al. Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia. American Journal of Hematology. 2025. doi:10.1002/ajh.70023
BibTeX
@article{MestreDurn2025,
author = {Mestre-Durán, Carmen and León-Triana, Odelaisy and Bareke, Halin and Pertíñez, Lidia and Clares-Villa, Laura and Bueno, David and Lozano-Ojalvo, Daniel and Navarro-Zapata, Alfonso and Sisinni, Luisa and Badell-Serra, Isabel and González-Vicent, Marta and Beléndez, Cristina and Palomo-Moraleda, Pilar and Mozo, Yasmina and Galán, Víctor and Artázcoz, Mikel Fernández and Echecopar, Carlos and Gasior, Mercedes and Al-Akioui, Karima and Cano-Ochando, Jordi and Guerra-García, Pilar and Fernández-Santos, María Eugenia and Aguirre-Portolés, Cristina and Pérez-Martínez, Antonio},
title = {Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.70023}
}
EUVIMED